Webcast CME

Pulmonary Hypertension Summit Webcasts

Pulmonary Arterial Hypertension Updates

Release date: 3/16/25
Expiration date:
3/15/27

Estimated Time of Completion: 3 hours

Session Agenda

PH Definition and Classification – How do I deal with Comorbidities?
David Badesch, MD,UCHealth University of Colorado Hospital

Risk Stratification in PAH – what is new?
Raymond L. Benza, MD, FACC, FAHA, FACP,Icahn School of Medicine at Mount Sinai

Updated PAH Treatment Algorithm
Vallerie McLaughlin, MD,
University of Michigan Health

The new kid on the (treatment) block – Sotatercept for PAH
PH Definition and Classification – How do I deal with Comorbidities?

David Badesch, MD,
UCHealth University of Colorado Hospital

Panel Discussion: Put it all together
Moderator: Roger Alvarez, DO, MPH, MS
Panel: David Badesch, MD, Raymond Benza, MD, FACC, FAHA, FACP, Vallerie McLauglin , MD

Description

Watch Pulmonary Hypertension Summit on-demand webcast series, recorded from the 2025 Pulmonary Hypertension Summit. The focus of the education is to provide you with an overview of the practical issues in the diagnosis, evaluation, and management of patients with pulmonary hypertension. Expert speakers present the most recent advances in the context of challenges faced by physicians and other health care providers caring for these patients. Additionally, the education addresses advances in diagnosis and risk stratification, emerging therapeutics, management of populations with concomitant disease, and technological innovations.

Learning Objectives

  • Detail the evidence base and clinical use of risk assessment tools and treatment algorithms for diagnosing, classifying, and treating pulmonary arterial hypertension.
  • Critically review the pharmacologic profile, efficacy and side effect data, and clinical indications for sotatercept and discuss its role in treating pulmonary arterial hypertension.
  • Highlight risks, benefits, and shared decision making.

Target Audience

The online series is directed to physicians, physician assistants, nurse practitioners, nurses, and pharmacists with an interest in pulmonary hypertension.

Accreditation

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians / American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 3.0 ANCC contact hours.

Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Pharmacists / Accreditation Council for Pharmacy Education (ACPE)
Cleveland Clinic Center for Continuing Education designates this knowledge-based activity for a maximum of 3.0 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

Universal Activity Number List: JA0000192-0000-25-230-H01-P 

Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.

Activity Director and Faculty

Activity Directors

Gustavo Heresi, MD
Medical Director, Pulmonary Thromboendarterectomy Program
Department of Pulmonary Medicine
Hospital Based Care Institute
Cleveland Clinic
Cleveland, OH

Neal Chaisson, MD
Director, Critical Care Medicine Fellowship
Department of Pulmonary and Critical Care Medicine
Hospital Based Care Institute
Cleveland Clinic
Cleveland, OH

Roger Alvarez, DO, MPH, MS
Medical Director, Pulmonary Hypertension and CTEPH Program
Cleveland Clinic Weston
Weston, FL

Samar Farha, MD
Department of Pulmonary and Critical Care Medicine
Hospital Based Care Institute
Cleveland Clinic
Cleveland, OH

Additional Planners

Alyssa Anderson, PA-C
Andrew Rich, PharmD
Mindy Rivera, CNS

Faculty

Roger Alvarez, DO, MPH, MS
Medical Director, Pulmonary Hypertension and CTEPH Program
Cleveland Clinic Weston

David Badesch, MD
UCHealth University of Colorado Hospital

Raymond L. Benza, MD, FACC, FAHA, FACP
Professor and System Director, Pulmonary Hypertension
Icahn School of Medicine at Mount Sinai
New York, NY

Vallerie McLaughlin, MD
Pulmonary Hypertension, Frankel Cardiovascular Center
University of Michigan Health
Ann Arbor, MI

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Faculty Disclosure

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias. All relevant financial relationships have been mitigated.

The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:

Roger A Alvarez, DO
United Therapeutics Corporation Consulting
Teaching and Speaking
Research
David Badesch, MD
Merck Consulting
Johnson & Johnson Ownership interest (stock, stock options in a publicly owned company)
United Therapeutics Corporation Research
Pfizer Research
AI Therapeutics Research
Raymond Benza, MD
Abbott Consulting
Neal Chaisson, MD
United Therapeutics Corporation Consulting
Teaching and Speaking
Bayer Advisor or review panel participant
Teaching and Speaking
Gustavo Heresi-Davila, MD
Bayer Healthcare Advisor of review panel participant
Teaching and Speaking
Research
Janssen Research & Development, LLC Advisor or review panel participant
Vallerie McLaughlin, MD
Aerovate Consulting
Research
Enzyvant Therapeutics GmpH Research
Gossamer Bio Consulting
Research
Keros Therapeutics Consulting
Research
Sonovie Research
Janssen Consulting
Research
Merck Consulting
Research
Apollo Consulting
CVS/Caremark Consulting
Corvista Consulting
Liquidia Consulting
Morphic Therapeutics Consulting
Regeneron Consulting
Respira Consulting
Riovant Consulting
United Therapeutics Corporation Consulting
Mindy Leann Rivera, CNS
Janssen Consulting
Teaching and Speaking
United Therapeutics Corporation Consulting
Teaching and Speaking

All other individuals have indicated no relationship which, in the context of their involvement, could be perceived as a potential conflict of interest.

Acknowledgment

The Cleveland Clinic Center for Continuing Education acknowledges educational grants for partial support of this activity from:

Bayer HealthCare Pharmaceuticals Inc.
ST Shared Services LLC, a Mallinckrodt company
Actelion Pharmaceuticals US, Inc.
United Therapeutics Corporation


This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education and Cleveland Clinic’s Hospital Based Care Institute.